06.06.2013 Views

Donepezil, rivastigmine, galantamine and memantine for ...

Donepezil, rivastigmine, galantamine and memantine for ...

Donepezil, rivastigmine, galantamine and memantine for ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Description of underlying health<br />

problem<br />

Dementia is a generic term describing chronic or<br />

progressive dysfunction of cortical <strong>and</strong> subcortical<br />

function that results in complex cognitive decline.<br />

These cognitive changes are commonly<br />

accompanied by disturbances of mood, behaviour<br />

<strong>and</strong> personality. 2 AD is the most common cause of<br />

dementia. Other causes of dementia include<br />

vascular dementia (VAD), dementia with Lewy<br />

bodies (DLB) <strong>and</strong> frontotemporal or frontal lobe<br />

dementia (FLD). 3–5<br />

Dementia in AD is a primary degenerative<br />

cerebral disease of unknown aetiology with<br />

characteristic neuropathological <strong>and</strong><br />

neurochemical features. The disorder is usually<br />

insidious in onset <strong>and</strong> it is difficult to set a clear<br />

threshold on the continuum between normality<br />

<strong>and</strong> dementia, but this is often defined when<br />

cognitive impairment is sufficient to interfere with<br />

normal social functioning. AD develops slowly but<br />

steadily over a period of several years.<br />

Progression of AD is characterised by a worsening<br />

of cognition (thinking, conceiving, reasoning <strong>and</strong><br />

memory), functional ability (e.g. activities of daily<br />

living) <strong>and</strong> behaviour <strong>and</strong> mood. Changes in one<br />

or more of these domains <strong>and</strong> their effects on the<br />

patient <strong>and</strong> their carers’ well-being provide the<br />

basis <strong>for</strong> diagnosis, assessing severity <strong>and</strong><br />

progression of the syndrome.<br />

Early onset AD<br />

AD is primarily a disease affecting the elderly.<br />

Although largely the same disease, early-onset AD<br />

(EOAD) is AD with an onset be<strong>for</strong>e age 65 years.<br />

It is a rare cause of the disease <strong>and</strong> these people<br />

often have a family history of the disease.<br />

Mutations in three genes have been identified in<br />

those with a strong family history of the disease<br />

[amyloid precursor protein (APP), presenilin-1 <strong>and</strong><br />

presenilin-2].<br />

Mixed dementia<br />

Despite a differentiation between VAD <strong>and</strong> AD,<br />

current evidence suggests there is some degree of<br />

overlap between the two disorders; a proportion of<br />

patients with dementia display both vascular <strong>and</strong><br />

Chapter 2<br />

Background<br />

© Queen’s Printer <strong>and</strong> Controller of HMSO 2006. All rights reserved.<br />

Health Technology Assessment 2006; Vol. 10: No. 1<br />

AD-type lesions. 6 This is often described as mixed<br />

dementia or atypical dementia.<br />

Risk factors<br />

AD is thought to be caused by many interacting<br />

factors. So far only age, family history <strong>and</strong> the E4<br />

allele of the APOE gene have been confirmed as<br />

risk factors <strong>for</strong> the disease. Other potential risk<br />

factors are hypertension, vascular pathology, head<br />

injury <strong>and</strong> herpes simplex infection. 2<br />

Diagnosis<br />

AD is the most common cause of dementia <strong>and</strong> its<br />

characteristic insidious onset with slow<br />

deterioration makes diagnosis difficult. In the<br />

majority of cases the diagnosis is one of exclusion;<br />

AD is diagnosed once other causes of dementia<br />

have been excluded. AD is diagnosed on the basis<br />

of a review of a full medical history corroborated<br />

by a close relative or carer, physical examination,<br />

blood investigations <strong>and</strong> mental state examination,<br />

including cognitive assessment. Definitive<br />

diagnosis of AD requires demonstration of<br />

pathological features in brain tissue such as<br />

degeneration of specific nerve cells <strong>and</strong> the<br />

presence of neuritic plaques <strong>and</strong> neurofibrillary<br />

tangles. This is usually made only on post-mortem<br />

examination. Several different diagnostic criteria<br />

<strong>for</strong> AD have been developed. The most generally<br />

accepted clinical diagnostic criteria are those of<br />

the National Institute of Neurological <strong>and</strong><br />

Communicative Disorders <strong>and</strong> Stroke <strong>and</strong> the<br />

Alzheimer’s Disease <strong>and</strong> Related Disorders<br />

Association (NINCDS-ADRDA) 7 (McKhann<br />

criteria), the Diagnostic <strong>and</strong> Statistical Manual of<br />

Mental Disorders (DSM), currently version IV<br />

(DSM-IV), <strong>and</strong> the International Classification of<br />

Diseases (ICD-10) (see Appendix 1).<br />

The NINCDS-ADRDA provides clinical guidance<br />

<strong>for</strong> ‘possible’, ‘probable’ <strong>and</strong> ‘definite’ diagnosis of<br />

AD. A diagnosis of possible AD is made when no<br />

other disease appears to be primarily responsible<br />

<strong>for</strong> the dementia or when the onset of symptoms<br />

is not typical of AD. A diagnosis of probable AD<br />

requires a patient to have dementia <strong>and</strong> a history<br />

<strong>and</strong> pattern of symptoms consistent with those<br />

generally seen in AD. Definite AD is diagnosed<br />

when evidence is shown through brain biopsy or at<br />

autopsy. The sensitivity <strong>and</strong> specificity of the<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!